Increased nuclear factor-κB activation is related to the tumor development of renal cell carcinoma

被引:106
作者
Oya, M [1 ]
Takayanagi, A
Horiguchi, A
Mizuno, R
Ohtsubo, M
Marumo, K
Shimizu, N
Murai, M
机构
[1] Keio Univ, Sch Med, Dept Urol, Shinjuku Ku, Tokyo 1608582, Japan
[2] Keio Univ, Sch Med, Dept Mol Biol, Shinjuku Ku, Tokyo 1608582, Japan
关键词
D O I
10.1093/carcin/24.3.377
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although an aggressive phenotype of renal cell carcinoma (RCC) is known to frequently be associated with inflammatory paraneoplastic syndrome including serum C-reactive protein (CRP) elevation, the molecular mechanism underlying this clinical phenomenon as well as what yields the malignant phenotype leading to the progression of RCC has yet to be elucidated. Based on the increased level of inflammatory cytokines such as interleukin-6 in advanced cases of RCC, a cytokine-inducible transcription factor, namely, nuclear factor-kappaB (NF-kappaB), may thus play a role in the progression of RCC. An electrophoretic mobility shift assay (EMSA) was carried out to determine the activity of NF-kappaB. Out of 45 cases of RCC, 15 cases (33%) showed a >200% increase in the NF-kappaB activity in comparison with that seen in normal renal tissue. In locally advanced cases (greater than or equal topT3), 64% (9/14) showed an increased activity whereas it was only observed in 19% (6/31) of localized cases (less than or equal topT2). All three cases with metastases showed an increased NF-kappaB activity. The NF-kappaB activity determined by EMSA was further confirmed by an immunohistochemical analysis using an antibody recognizing the nuclear localization signal (NLS) in p65 subunit of NF-kappaB. The serum CRP elevation correlated with the increased NF-kappaB activation, and therefore NF-kappaB may be a causative transcription factor of inflammatory paraneoplastic syndrome. A high NF-kappaB activity was associated with an increased expression of both the p65 and p50 subunits of NF-kappaB and a concomitant decreased expression of IkappaBalpha. No functional mutations of the IkappaBalpha gene were detected. The NF-kappaB activity may therefore be a late event in carcinogenesis related to tumor development, thereby representing a possible molecular target in the treatment of RCC.
引用
收藏
页码:377 / 384
页数:8
相关论文
共 35 条
  • [1] Blay JY, 1997, INT J CANCER, V72, P424, DOI 10.1002/(SICI)1097-0215(19970729)72:3<424::AID-IJC9>3.0.CO
  • [2] 2-R
  • [3] BLAY JY, 1992, CANCER RES, V52, P3317
  • [4] THE NF-KAPPA-B TRANSCRIPTION FACTOR AND CANCER - HIGH EXPRESSION OF NF-KAPPA-B- AND I-KAPPA-B-RELATED PROTEINS IN TUMOR-CELL LINES
    BOURS, V
    DEJARDIN, E
    GOUJONLETAWE, F
    MERVILLE, MP
    CASTRONOVO, V
    [J]. BIOCHEMICAL PHARMACOLOGY, 1994, 47 (01) : 145 - 149
  • [5] BROWN LF, 1993, AM J PATHOL, V143, P1255
  • [6] Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα
    Cabannes, E
    Khan, G
    Aillet, F
    Jarrett, RF
    Hay, RT
    [J]. ONCOGENE, 1999, 18 (20) : 3063 - 3070
  • [7] AUTOREGULATION OF I-KAPPA-B-ALPHA ACTIVITY
    CHIAO, PJ
    MIYAMOTO, S
    VERMA, IM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (01) : 28 - 32
  • [8] Genomic organization of human and mouse genes for vascular endothelial growth factor C
    Chilov, D
    Kukk, E
    Taira, S
    Jeltsch, M
    Kaukonen, J
    Palotie, A
    Joukov, V
    Alitalo, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (40) : 25176 - 25183
  • [9] ELEVATED SERUM LEVELS OF C-REACTIVE PROTEIN IN HEMODIALYSIS-PATIENTS
    DOCCI, D
    BILANCIONI, R
    BUSCAROLI, A
    BALDRATI, L
    CAPPONCINI, C
    MENGOZZI, S
    TURCI, F
    FELETTI, C
    [J]. NEPHRON, 1990, 56 (04): : 364 - 367
  • [10] Renal cell carcinoma: Management of advanced disease
    Figlin, RA
    [J]. JOURNAL OF UROLOGY, 1999, 161 (02) : 381 - 386